IBDEI1EK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22433,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,22433,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,22434,0)
 ;;=N76.1^^102^1141^230
 ;;^UTILITY(U,$J,358.3,22434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22434,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,22434,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,22434,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,22435,0)
 ;;=B97.89^^102^1141^249
 ;;^UTILITY(U,$J,358.3,22435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22435,1,3,0)
 ;;=3^Viral syndrome
 ;;^UTILITY(U,$J,358.3,22435,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,22435,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,22436,0)
 ;;=Z77.21^^102^1141^88
 ;;^UTILITY(U,$J,358.3,22436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22436,1,3,0)
 ;;=3^Exposure to potentially hazardous bodily fluids
 ;;^UTILITY(U,$J,358.3,22436,1,4,0)
 ;;=4^Z77.21
 ;;^UTILITY(U,$J,358.3,22436,2)
 ;;=^5063323
 ;;^UTILITY(U,$J,358.3,22437,0)
 ;;=Z72.51^^102^1141^124
 ;;^UTILITY(U,$J,358.3,22437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22437,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,22437,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,22437,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,22438,0)
 ;;=Z20.828^^102^1141^47
 ;;^UTILITY(U,$J,358.3,22438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22438,1,3,0)
 ;;=3^Contact or exposure to other viral diseases
 ;;^UTILITY(U,$J,358.3,22438,1,4,0)
 ;;=4^Z20.828
 ;;^UTILITY(U,$J,358.3,22438,2)
 ;;=^5062774
 ;;^UTILITY(U,$J,358.3,22439,0)
 ;;=Z79.899^^102^1141^150
 ;;^UTILITY(U,$J,358.3,22439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22439,1,3,0)
 ;;=3^Long term use of medications
 ;;^UTILITY(U,$J,358.3,22439,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,22439,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,22440,0)
 ;;=Z23.^^102^1141^76
 ;;^UTILITY(U,$J,358.3,22440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22440,1,3,0)
 ;;=3^Encounter for immunization
 ;;^UTILITY(U,$J,358.3,22440,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,22440,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,22441,0)
 ;;=A08.4^^102^1141^100
 ;;^UTILITY(U,$J,358.3,22441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22441,1,3,0)
 ;;=3^Gastroenteritis, viral
 ;;^UTILITY(U,$J,358.3,22441,1,4,0)
 ;;=4^A08.4
 ;;^UTILITY(U,$J,358.3,22441,2)
 ;;=^5000059
 ;;^UTILITY(U,$J,358.3,22442,0)
 ;;=B16.9^^102^1141^109
 ;;^UTILITY(U,$J,358.3,22442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22442,1,3,0)
 ;;=3^Hepatitis B, acute
 ;;^UTILITY(U,$J,358.3,22442,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,22442,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,22443,0)
 ;;=B18.1^^102^1141^110
 ;;^UTILITY(U,$J,358.3,22443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22443,1,3,0)
 ;;=3^Hepatitis B, chronic without coma
 ;;^UTILITY(U,$J,358.3,22443,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,22443,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,22444,0)
 ;;=B17.10^^102^1141^112
 ;;^UTILITY(U,$J,358.3,22444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22444,1,3,0)
 ;;=3^Hepatitis C, acute
 ;;^UTILITY(U,$J,358.3,22444,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,22444,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,22445,0)
 ;;=B18.2^^102^1141^113
 ;;^UTILITY(U,$J,358.3,22445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22445,1,3,0)
 ;;=3^Hepatitis C, chronic without coma
 ;;^UTILITY(U,$J,358.3,22445,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,22445,2)
 ;;=^5000548
